As the second annual Microsoft Business Intelligence Conference opens, Microsoft BI tools empower information workers and drive performance at pharmaceutical leader Merck Co., Inc., highlighting market momentum. SEATTLE.—...
SAN DIEGO, Oct 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems...
A study concludes that in the ten years since its initiation, the international effort to eliminate lymphatic filariasis has made a large impact towards eradication of the disease. These efforts are the result of the most rapid...
Merck KGaA, together with its Merck Serono division, announced that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had received ...
WHITEHOUSE STATION, N.J., Oct. 2, 2008 - Merck & Co., Inc., today announced that it has awarded five grants totaling $250,000 to AmeriCares, Catholic Medical Mission Board (CMMB), Direct Relief International, IMA World Health...
SUPERVALU INC.(R) (NYSE: SVU), one of the largest companies in the U.S. grocery channel whose nationwide family of stores includes ACME(R), ALBERTSONS(R), bigg's(R), CUB FOODS(R), FARM FRESH(R), HORNBACHER'S(R), JEWEL-OSCO(R),...
CAMBRIDGE, Mass.----ARIAD Pharmaceuticals, Inc. today announced that the U.S. District Court for the District of Delaware granted ARIAD's motion to permit an immediate appeal of the Court's summary judgment ruling of...
Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III...
Shares of drugmaker Pfizer Inc. hit their lowest level in more than a decade Monday as U.S. and global stock markets were in freefall amid widening fears over whether financial bailouts can unfreeze credit markets and stabilize...
Leading Indian healthcare group Apollo Hospitals (BSE:508869) Saturday entered into an agreement with the Indian arm of US-based drug maker Merck & Co to jointly set up 200 exclusive clinics to treat diabetes in India.